Financial Ratios

PROCTER & GAMBLE HEALTH LTD.

NSE : PGHLBSE : 500126ISIN CODE : INE199A01012Industry : Pharmaceuticals & DrugsHouse : Merck - MNC
BSE5820.00-19.05 (-0.33 %)
PREV CLOSE ( ) 5839.05
OPEN PRICE ( ) 5839.95
BID PRICE (QTY) 5810.35 (5)
OFFER PRICE (QTY) 5831.45 (2)
VOLUME 223
TODAY'S LOW / HIGH ( )5736.65 5840.00
52 WK LOW / HIGH ( )4905.65 6107.55
NSE5806.00-25 (-0.43 %)
PREV CLOSE( ) 5831.00
OPEN PRICE ( ) 5831.00
BID PRICE (QTY) 5803.00 (1)
OFFER PRICE (QTY) 5808.50 (1)
VOLUME 2765
TODAY'S LOW / HIGH( ) 5712.00 5831.00
52 WK LOW / HIGH ( )4863 6175.5
Select year
ParticularsJun2024Jun2023Jun2022Jun2021Jun2020
Operational & Financial Ratios
   Earnings Per Share (Rs)121.07138.23115.98106.51153.06
   CEPS(Rs)137.58155.16132.29124.60170.80
   DPS(Rs)260.0095.0052.50130.00230.00
   Book NAV/Share(Rs)319.10447.62366.99421.59544.82
   Tax Rate(%)26.4726.9724.0224.2128.40
Margin Ratios
   Core EBITDA Margin(%)24.3024.4422.7324.3923.18
   EBIT Margin(%)21.7623.7121.5523.2126.17
   Pre Tax Margin(%)21.7123.6621.5123.1326.17
   PAT Margin (%)15.9617.2816.3517.5318.74
   Cash Profit Margin (%)18.1419.3918.6420.5020.91
Performance Ratios
   ROA(%)9.4911.009.838.6510.82
   ROE(%)31.5833.9429.4122.0420.79
   ROCE(%)42.5246.0738.4529.0829.01
   Asset Turnover(x)0.590.640.600.490.58
   Sales/Fixed Asset(x)5.185.275.174.877.04
   Working Capital/Sales(x)4.122.703.132.071.87
Efficiency Ratios
   Fixed Capital/Sales(x)0.190.190.190.210.14
   Receivable days29.1427.3622.2028.0621.73
   Inventory Days35.3734.3736.1945.6833.31
   Payable days223.07206.35188.51177.0990.99
Valuation Parameters
   PER(x)41.7137.9736.1052.5226.57
   PCE(x)36.7133.8331.6544.8923.81
   Price/Book(x)15.8311.7311.4113.277.47
   Yield(%)5.151.811.252.325.65
   EV/Net Sales(x)7.076.735.958.744.51
   EV/Core EBITDA(x)25.3024.1223.5933.3815.91
   EV/EBIT(x)29.7026.2726.1137.6717.23
   EV/CE(x)15.1211.023.424.462.89
   M Cap / Sales7.287.096.249.214.98
Growth Ratio
   Net Sales Growth(%)-6.3710.3410.48-25.6059.70
   Core EBITDA Growth(%)-6.2522.156.34-31.27122.73
   EBIT Growth(%)-12.9924.118.42-34.03124.62
   PAT Growth(%)-12.4219.198.89-30.42149.73
   EPS Growth(%)-12.4219.198.89-30.42149.73
Financial Stability Ratios
   Total Debt/Equity(x)0.000.000.000.000.00
   Current Ratio(x)1.491.721.621.892.35
   Quick Ratio(x)1.311.531.431.672.10
   Interest Cover(x)380.61409.05604.26292.60
   Total Debt/Mcap(x)0.000.000.000.000.00

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.